Quality Assurance Peer Review of Head and Neck Contours in a Large Cancer Centre via a Weekly Meeting Approach.


Journal

Clinical oncology (Royal College of Radiologists (Great Britain))
ISSN: 1433-2981
Titre abrégé: Clin Oncol (R Coll Radiol)
Pays: England
ID NLM: 9002902

Informations de publication

Date de publication:
06 2019
Historique:
received: 10 10 2018
revised: 01 02 2019
accepted: 04 02 2019
pubmed: 21 3 2019
medline: 15 4 2020
entrez: 21 3 2019
Statut: ppublish

Résumé

To assess the impact of weekly scheduled peer review of head and neck contours for definitive and adjuvant radiotherapy cases based on rates of recommended changes. Retrospective analysis of a prospective database. Recommended changes were prospectively classified as 'major' (change in gross tumour volume and/or high-dose clinical target volume, dose/fractionation) or 'minor' (change in intermediate or elective dose clinical target volumes or organs at risk). Univariate analysis to explore associations between recommended changes and tumour site/stage and radical/adjuvant indication. In total, 307/375 (82%) head and neck cases treated with volumetric-modulated arc therapy were prospectively peer reviewed over a 12-month period; 195 (64%) cases received definitive and 112 (36%) received adjuvant radiotherapy. Overall, 43/307 (14.0%) changes were recommended within the peer review meetings. This comprised 27/307 (8.8%) major changes and 16/307 (5.2%) minor changes; 33/43 (77%) changes were in the clinical target volume. Rates of recommended changes were significantly higher for adjuvant versus definitive radiotherapy (odds ratio 2.26, P = 0.014) and for larynx compared with oropharynx (odds ratio 3.02, P = 0.02). There was no overall correlation between clinician experience and rates of change (P = 0.62). Routine weekly meeting contour-based peer review resulted in a number of major and minor changes to treatment. Compliance was high. Peer review was potentially beneficial for all tumour sites/stages/indications and any degree of clinician experience.

Identifiants

pubmed: 30890299
pii: S0936-6555(19)30092-5
doi: 10.1016/j.clon.2019.03.001
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

344-351

Informations de copyright

Copyright © 2019 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Auteurs

S Ramasamy (S)

Department of Clinical Oncology, Leeds Cancer Centre, Leeds, UK.

L J Murray (LJ)

Department of Clinical Oncology, Leeds Cancer Centre, Leeds, UK.

K Cardale (K)

Department of Clinical Oncology, Leeds Cancer Centre, Leeds, UK.

K E Dyker (KE)

Department of Clinical Oncology, Leeds Cancer Centre, Leeds, UK.

P Murray (P)

Department of Clinical Oncology, Leeds Cancer Centre, Leeds, UK.

M Sen (M)

Department of Clinical Oncology, Leeds Cancer Centre, Leeds, UK.

R J D Prestwich (RJD)

Department of Clinical Oncology, Leeds Cancer Centre, Leeds, UK. Electronic address: Robin.Prestwich@nhs.net.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH